Herbert Y Meltzer, MD, is Professor of Psychiatry and Behavioral Sciences and Professor of Pharmacology and Physiology at the Feinberg School of Medicine Chicago, Il. He is Past President of the American College of Neuropsychopharmacology (ACNP) and the Collegium International Neuro-psychopharmacologicum (CINP). He has over 900 peer-reviewed publications and 150 book chapters, relating to schizophrenia, mood disorders and suicide, and addressing both clinical and basic neuroscience aspects of cognition.

Dr. Meltzer is the recipient of numerous awards for his research in schizophrenia, mood disorders, and suicide, including the Lieber Prize for Schizophrenia Research from the Brain and Behavior Research Foundation (NARSAD), , the Stanley Dean Award for Research in Schizophrenia of the American College of Psychiatry, the Gold Medal Award of the Society of Biological Psychiatry, the Research Prize of the American Psychiatric Association, Lifetime Achievement awards of the Winter Conference on Psychosis Research and the Schizophrenia International Research Society, and the CINP Pioneer Award (2016). His Hirsch index is 112; his publications have been cited over 50,000 times.

Dr. Meltzer’s major research interests include:

  1. the development of genetic biomarkers for personalized medicine in psychiatry;
  2. the discovery, development, and optimal utilization of antipsychotic drugs, rapidly acting antidepressants, cognitive enhancers, and other novel pharmacologic treatments for schizophrenia and related disorders, including bipolar disorder;
  3. the causes and novel treatments for cognitive impairment in schizophrenia and bipolar disorder;
  4. the elucidation of the mechanism of action of antipsychotic and other psychotropic drugs, especially the role of 5-HT2A and 5-HT1A receptors;
  5. the causes and prevention of suicide.